The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
4963115 6160385 F 4963115-5 20060211 20060327 20060405 EXP ES-GLAXOSMITHKLINE-B0419016A GLAXOSMITHKLINE 85 YR M Y 20060405 CN SPAIN

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
4963115 1007131893 PS AMOXICILLIN + CLAVULANATE POTASSIUM 1 ORAL 50564
4963115 1007131894 C ADIRO 2 ORAL 100MG PER DAY
4963115 1007131895 C OMEPRAZOLE 1 ORAL 20MG PER DAY
4963115 1007131896 C ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE 1 ORAL

Indications of drugs used

Event ID DRUG SEQ INDI PT
4963115 1007131893 UPPER RESPIRATORY TRACT INFECTION
4963115 1007131894 ESSENTIAL HYPERTENSION
4963115 1007131895 PROPHYLAXIS
4963115 1007131896 ESSENTIAL HYPERTENSION

Outcome of event

Event ID OUTC COD
4963115 HO

Reactions reported

Event ID PT
4963115 HEPATITIS CHOLESTATIC

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
4963115 1007131893 20060201 20060212
4963115 1007131894 20050101
4963115 1007131895 20050101 20060214
4963115 1007131896 20050101 20060214